Anupam Rasayan India Ltd. · NSE:ANURAS
Anupam Rasayan India — Q3 FY2025 Earnings Presentation
26 slides from Anupam Rasayan India's earnings presentation, Feb 13, 2025
Slide 1: Exchange filing cover letter: Investor Presentation
ANUPAM RASAYAN INDIA LTD. R ARILSLDSTX20250213076 Date: February 13, 2025 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, ‘Exchange Plaza’, C-1, Block-G, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai-400001, India Mumbai-400051, India SCRIP CODE: 5
Slide 2: Anupam Rasayan India Limited Q3FY25
Anupam Rasayan India Limited Q3FY25 February 2025
Slide 3: Quarterly Highlights
Quarterly Highlights 1 2 Anupam Rasayan India Limited \
Slide 4: Quarterly Financial Highlights
3 Quarterly Financial Highlights \ Limited India Consolidated EBITDA (Incl. Rasayan Consolidated Total Consolidated PAT stood Revenue was ₹ 3,866 Mn; Other Revenue) was ₹ 1,208 at ₹ 542 Mn.; Q-o-Q Q-o-Q growth of 31% Mn.; margin stands at 31% growth of 77% Anupam Standalone Total Revenue Standalone
Slide 5: Managing Director's Message
4 Managing Director’s Message \ Limited “Our Pharma and Polymer segments, which have emerged as key growth India drivers, continue to strengthen their contribution to our revenue. Both the segments coupled with strong performance of Tanfac led to significant growth Rasayan this quarter, fueling a ro
Slide 6: Nine Month Financials: Consolidated Profit & Loss Summary
5 NINE MONTH FINANCIALS Consolidated Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) 9MFY25 9MFY24 INCOME: India Revenue from Operations 9,383 10,741 Other Income 45 182 Total Revenue 9,428 10,923 Rasayan EXPENSES: Cost of Raw Materials Consumed 3,670 4,265 Gross Profit 5,713 6,476 Anupam
Slide 7: Quarterly Financials: Consolidated Profit & Loss Summary
6 QUARTERLY FINANCIALS Consolidated Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) Q3FY25 Q3FY24 INCOME: India Revenue from Operations 3,901 2,955 Other Income (35) 24 Total Revenue Rasayan 3,866 2,979 EXPENSES: Cost of Raw Materials Consumed 1,566 1,009 Gross Profit Anupam 2,335 1,946 Gr
Slide 8: Nine Month Financials: Standalone Profit & Loss Summary
7 NINE MONTH FINANCIALS Standalone Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) 9MFY25 9MFY24 INCOME: India Revenue from Operations 5,667 8,202 Other Income 65 148 Total Revenue 5,733 8,351 Rasayan EXPENSES: Cost of Raw Materials Consumed 1,757 2,911 Gross Profit 3,911 5,292 Anupam Gros
Slide 9: Quarterly Financials: Standalone Profit & Loss Summary
8 QUARTERLY FINANCIALS Standalone Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) Q3FY25 Q3FY24 INCOME: India Revenue from Operations 2,121 2,147 Other Income (29) 14 Total Revenue 2,092 2,161 Rasayan EXPENSES: Cost of Raw Materials Consumed 640 574 Gross Profit 1,481 1,573 Anupam Gross Ma
Slide 10: Business Overview
Business Overview 2 9 Anupam Rasayan India Limited \
Slide 11: Company at a glance
10 Innovating Sustainable & Custom Solutions for Global Markets \ Limited Company at a glance India Established Custom Specializes in multi-step Catering to globally Strong supply chain Synthesis player with 40 synthesis undertaking relevant chemical & with backward Rasayan years of track record com
Slide 12: Evolution of Anupam Rasayan
11 Evolution of \ Phase II- Limited Phase I-Inception Anupam The Acceleration India • Raised ₹5,000 mn. through QIP Formed Rasayan • Commissioned Solar partnership firm Power Plant of 5.4MW “Anupam Rasayan” at Bharuch • Fast growing Anupam Specialty Chemical Acquired ~26% Manufacturer with Started s
Slide 13: Chemical Conduits and Global Partnerships
12 Chemical Conduits and Global Partnerships \ Limited India Business Verticals Overview Few of our top global clients Rasayan Life Science Related Performance Materials Specialty Chemicals Agrochemicals Anupam (including Crop Protection) Polymer Manufacturing agro intermediates and agro active ingr
Slide 14: Charting New Frontiers with R&D Excellence
13 Charting New Frontiers with R&D Excellence \ Limited Process technologies deployed India Flow Chemistry Photo Chemistry • Reduced lead time • Simplified Rasayan • Material efficient & synthesis of cost benefits complex molecules • Lesser • Larger potential for environmental automation impacts in
Slide 15: Experienced Leadership & Deep Technical Talent Pool
14 Experienced Leadership & Deep Technical Talent Pool \ Limited India Mr. Anand S Desai Mrs. Mona A Desai Rasayan Managing Director Vice-chairman & Whole-time Director Over 30 years of experience in chemicals Over 20 years of experience in chemicals industry associated with company since 1992 & ind
Slide 16: Strong global business development team
We have also built a strong global business development team to strengthen our presence in key target markets U N I T E D S TAT E S Mr. John Grant Business Advisor - Specialty Fluoro Chemicals 30 years+ of experience in Chemicals industry; former business development at 3M Mr. Rob Bryant JA PA N Bus
Slide 17: Growth Drivers
Drivers Growth 3 16 Anupam Rasayan India Limited \
Slide 18: Growth Drivers
17 Growth Drivers \ Limited India Rasayan 1 2 3 Anupam Growth of Execution of Expansion in Polymer and Signed LOIs and Fluorination Pharma Product Contracts chemistry Portfolio
Slide 19: Growth of Pharma and Polymer Portfolio
18 Growth of Pharma and Polymer Portfolio \ Limited New Strategic Custom 65+ 6+ India Development Products under pipeline to be manufactured by Number of molecules of Number of molecules in Rasayan Anupam in India: pharma and polymer in pharma and polymer to be R&D and pilot commercialized in FY25 A
Slide 20: Pharmaceuticals: Large, fast-growing market
Pharmaceuticals: Large, fast-growing market; 10+ molecules commercialized, 19 \ 30+ molecules under pilot/ R&D Limited …and are targeting a large ~$15B TAM with We have made significant progress in Pharma … significant growth India Rasayan Focus segment for Anupam: High-value KSM/intermediates 10+ 2
Slide 21: Polymer & Electronic chemicals: global marquee customers
Polymer & Electronic chemicals: Made significant strides with focus on global 20 \ marquee customers across multiple industries Limited Forayed into polymer by working with leading global …across major emerging applications with a ~$10B innovators … growing TAM India Rasayan 2 Leading Anupam High-va
Slide 22: Strong Order Book – Recent LOI/Contracts Signed
21 Strong Order Book – Recent LOI/Contracts Signed \ Limited Signing Quarter Segment Customer LOI/Contract Tenor (Years) Status Value(₹ Crores) Multinational Life Science India Q1FY22 Life Science LOI 5 Commercialized ₹1,100 Company Q1FY22 Life Science Two Multinational Companies Contract 5 Commerci
Slide 23: Strategic Expansion in Fluorination with Tanfac
22 Anupam’s Strategic Expansion in Fluorination with Tanfac \ Limited Anupam acquired ~26% stake in India Tanfac for ~₹1,530M in May'22 Rasayan Producer of Leading Anupam fluorinated producer of intermediates KF/HF • Specialty fluoride chemical Anupam Tanfac manufacturer in India Only Indian • Leadi
Slide 24: Expansion in Fluorination Chemistry
23 Expansion in Fluorination Chemistry \ Limited FOCUSED SEGMENTS MOLECULES END APPLICATION CUSTOMER SEGMENT REVENUE India POTENTIAL Product A Elastomer US MNC Rasayan Polymers $ 40 – 70 Mn. Product B Semiconductor/Flame Retardant Japanese MNC Anupam Product X/Y Cardio/Anti-viral Indian MNC Pharmace
Slide 25: Summary: Strengths and Key Highlights
24 Summary \ Limited Strengths and Key Highlights India • Doubled manufacturing capacity in the last three years Rasayan Manufacturing • Strong capex plans to expand capacity into newer Prowess molecules / chemistries Anupam R&D • DSIR recognized R&D center with a team of 88 R&D professionals Capabi
Slide 26: Thank You
Corporate Office ANUPAM Anupam Rasayan India Ltd. India (HQ) 10th Floor, Icon Rio, Dumas Road, Surat, Gujarat, RASAYAN INDIA India – 395 007 LIMITED ThankYou BSE: 543275 | NSE: ANURAS | ISIN: INE930P01018 ©2022 – Anupam Rasayan India Limited, All Rights Reserved. DRAFT
Anupam Rasayan India — Q3 FY2025 Earnings Presentation on 6ix